Biotech company Amgen (NASDAQAMGN) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 10.9% year on year to $9.09 billion. The company’s full-year revenue guidance of $35 billion at the midpoint came in 1.4% above analysts’ estimates. Its non-GAAP profit of $5.31 per share was 4.6% above analysts’ consensus estimates.
While Southeast Asia shares most of the energy problems of the rest of the world, it seems that this region is somewhat better placed to handle the energy shortfalls that lie ahead than many other regions.
Online advertising giant Alphabet (NASDAQGOOGL) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 11.8% year on year to $96.47 billion. Its GAAP profit of $2.15 per share was 1.2% above analysts’ consensus estimates.
Telecom company Lumen Technologies (NYSELUMN) reported Q4 CY2024 results exceeding the market’s revenue expectations, but sales fell by 5.3% year on year to $3.33 billion. Its non-GAAP profit of $0.09 per share was significantly above analysts’ consensus estimates.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top S&P500 gainers and losers in today's session.
Vanguard's fee cuts may not significantly affect BlackRock, as the latter has a more diversified ETF strategy and mainly caters to institutional investors.
President Donald Trump’s newly appointed "Crypto Czar" David Sacks on Tuesday announced the formation of a bipartisan, bicameral committee to establish a clear regulatory framework for the digital asset industry.
Dogecoin (CRYPTO: DOGE) and Shiba Inu (CRYPTO: SHIB) are showing steady price action, but on-chain data and technical indicators suggest a massive rally could be
Robert F. Kennedy Jr. didn't win the 2024 presidential election, but could find his way into President Donald Trump's cabinet as the leader of the Department of Health and Human Services.
Shares of consumer products giant Clorox (NYSECLX)
fell 7% in the afternoon session after the company reported underwhelming fourth quarter results, with revenue down 15%, reflecting inventory normalization and the sale of the Better Health Vitamins, Minerals & Supplements (VMS) and Argentina businesses. This marks a sharp reversal from the 16% growth a year ago. The previous year's numbers got a temporary lift when Clorox restocked stores after the August 2023 cyberattack. That boost didn't repeat, making sales look weaker this quarter. Also, organic sales fell 9%, showing that core operations are struggling.
Looking ahead, the company expects full-year sales to stay the same, aside from a 1-2% boost from extra shipments tied to the Enterprise Resource Planning (ERP) switch, which isn't expected to recur.
Shares of action camera company GoPro (NASDAQGPRO)
jumped 9% in the afternoon session after it clarified in a press release that it expects its diversified supply chain to soften the blow of U.S. tariffs. As a result, the company doesn't expect the new tariffs to affect its prices in the U.S. or hurt its gross margins for goods shipped to the U.S. Brian McGee, CFO and COO added, "Over the last few years, we proactively moved our U.S.-bound camera production outside of China, which has significantly reduced the impact of tariffs."
Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Tuesday and discover the stocks that are dominating the trading activity and setting the pace for the market.
